BioMark Diagnostics Inc C.BUX

Alternate Symbol(s): BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat cancers. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. Its oncology has developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections.

CSE:BUX - Post by User

BioMark Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

Post by geodcanon Feb 07, 2021 5:56pm

137 Views

Post# 32497036

Solid

volume building and sp appreciation. Maybe friends and family listened to somebody talking in their sleep and got excited or maybe Questrade or Berkeley bringing in some players. glta and dyodd

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland